Skip to main content
Year archive

Leadway Technology Investment Group Limited — 2024 filings

All 93 regulatory filings released by Leadway Technology Investment Group Limited (2086) in 2024, sourced directly from the official regulator.

93 Filings
2024 Period
2024 filings (93)
Filing Released Lang
List of Directors and their Roles and Functions
Board/Management Information
2024-12-30 English
Appointment of Executive Director
Board/Management Information
2024-12-30 English
Poll Results of the Extraordinary General Meeting held on 30 December 2024
Declaration of Voting Results & Voting Rights Announcements
2024-12-30 English
Discloseable Transactions - Proposed Share Repurchase(s) and Proposed Adoption of Share Award Scheme by a Listed Subsidiary
Transaction in Own Shares
2024-12-20 English
Announcement Pursuant to Rule 13.18 of the Listing Rules
Capital/Financing Update
2024-12-11 English
Notification Letter to Non-registered Shareholders and Request Form
Report Publication Announcement
2024-12-04 English
Notification Letter to Existing Shareholders and Request Form
Report Publication Announcement
2024-12-04 English
Notice of Extraordinary General Meeting
Proxy Solicitation & Information Statement
2024-12-04 English
Form of Proxy for Extraordinary General Meeting to be held on 30 December 2024
Proxy Solicitation & Information Statement
2024-12-04 English
Renewal of Existing Continuing Connected Transactions with Tianjin TEDA Investment Holding Co., Ltd. and Notice of Extraordinary General Meeting
Regulatory Filings
2024-12-04 English
Renewal of Existing Continuing Connected Transactions with Tianjin TEDA Investment Holding Co., Ltd. and Notice of Extraordinary General Meeting
Proxy Solicitation & Information Statement
2024-12-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2024
Regulatory Filings
2024-12-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
Regulatory Filings
2024-12-02 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2024-11-25 English
Renewal of Existing Continuing Connected Transactions and Entering Into of New Continuing Connected Transactions with Tianjin TEDA Investment Holding Co., Ltd.
Regulatory Filings
2024-11-15 English
Renewal of Existing Continuing Connected Transactions with Tianjin Pharmaceutical Group Co., Ltd.
Regulatory Filings
2024-11-15 English
(I) CHANGE OF AUDITOR AND (II) CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
Board/Management Information
2024-11-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2024
Regulatory Filings
2024-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
Transaction in Own Shares
2024-11-01 English
Unaudited Financial Results for the nine months ended 30 September 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report 9M 2024
2024-10-29 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
Regulatory Filings
2024-10-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2024
Regulatory Filings
2024-10-02 English
Discloseable Transaction - Subscription of Wealth Management Product
Capital/Financing Update
2024-09-26 English
Notification Letter to Non-registered Shareholders and Request Form
Report Publication Announcement
2024-09-17 English
Notification Letter to Existing Shareholders and Request Form
Report Publication Announcement
2024-09-17 English
2024 Interim Report
Interim / Quarterly Report H1 2024
2024-09-17 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2024
Regulatory Filings
2024-09-05 English
Interim Report 2024
Interim / Quarterly Report H1 2024
2024-09-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
Regulatory Filings
2024-09-02 English
Continuing Connected Transactions - Products Procurement Master Agreement and Integrated Services Master Agreement
Regulatory Filings
2024-08-29 English
Interim Dividend for the six months ended 30 June 2024
Notice of Dividend Amount
2024-08-29 English
Announcement of Interim Results for the six months ended 30 June 2024
Interim / Quarterly Report H1 2024
2024-08-29 English
Unaudited Financial Results for the six months ended 30 June 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report H1 2024
2024-08-23 English
CONTINUING CONNECTED TRANSACTION COOPERATION AGREEMENT
Regulatory Filings
2024-08-20 English
Date of Board Meeting
Report Publication Announcement
2024-08-19 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2024
Interim / Quarterly Report H1 2024
2024-08-12 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2024
Regulatory Filings
2024-08-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
Regulatory Filings
2024-08-01 English
POSITIVE PROFIT ALERT
Earnings Release H1 2024
2024-07-26 English
NOTICE OF BOARD MEETING
Regulatory Filings
2024-07-26 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2024
Regulatory Filings
2024-07-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
Regulatory Filings
2024-07-02 English
Discloseable Transaction - Disposal of 24.65% Equity Interest in Tianjin Tanabe Seiyaku Co., Ltd.
Capital/Financing Update
2024-06-28 English
Articles of Association
Governance Information
2024-06-13 English
Poll Results of the Annual General Meeting held on 13 June 2024
Declaration of Voting Results & Voting Rights Announcements
2024-06-13 English
Discloseable Transaction - Subscription of Wealth Management Products
Capital/Financing Update
2024-06-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2024
Regulatory Filings
2024-06-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
Regulatory Filings
2024-06-03 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 27 MAY 2024
Declaration of Voting Results & Voting Rights Announcements
2024-05-27 English
Potential Disposal of 24.65% Equity Interest in Tianjin Tanabe Seiyaku Co., Ltd.
Capital/Financing Update
2024-05-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2024
Regulatory Filings
2024-05-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
Regulatory Filings
2024-05-02 English
Unaudited Financial Results for the three months ended 31 March 2024 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report Q1 2024
2024-04-25 English
Notification Letter to Non-registered Shareholders and Request Form
Report Publication Announcement
2024-04-25 English
Notification Letter to Existing Shareholders and Request Form
Report Publication Announcement
2024-04-25 English
Notice of Annual General Meeting
AGM Information
2024-04-25 English
Form of Proxy for Annual General Meeting to be held on 13 June 2024
AGM Information
2024-04-25 English
General Mandates to Issue Shares and to Buy Back Shares, Declaration of Final Dividend, Re-election of Directors, Proposed Adoption of the New Articles of Association and Notice of Annual General Meet
AGM Information
2024-04-25 English
Annual Report 2023
Annual Report FY 2023
2024-04-25 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (or at any adjournment thereof)
Proxy Solicitation & Information Statement
2024-04-18 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF THE RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2024-04-18 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2024-04-18 English
Annual Report 2023
Annual Report FY 2023
2024-04-18 English
Letter to Non-registered Shareholder - Electronic Dissemination of Corporate Communications and Reply Form
Regulatory Filings
2024-04-05 English
Letter to Registered Shareholder - Electronic Dissemination of Corporate Communications and Reply Form
Regulatory Filings
2024-04-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Regulatory Filings
2024-04-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024
Regulatory Filings
2024-04-02 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2024-03-27 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Annual Report FY 2023
2024-03-27 English
List of Directors and their Roles and Functions
Board/Management Information
2024-03-27 English
Change of Chairman of the Board, Authorised Representative and Change in Composition of Nomination Committee, Remuneration Committee and Investment Committee
Board/Management Information
2024-03-27 English
Final Dividend for the year ended 31 December 2023
Notice of Dividend Amount
2024-03-27 English
Annoucement of Final Results for the year ended 31 December 2023
Annual Report FY 2023
2024-03-27 English
Audited Financial Results for the year ended 31 December 2023 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Annual Report FY 2023
2024-03-21 English
Date of Board Meeting
Regulatory Filings
2024-03-15 English
Material Variation of the Terms of Connected Transaction in relation to the Partnership Agreement
Regulatory Filings
2024-03-14 English
Positive Profit Alert
Earnings Release FY 2023
2024-03-13 English
NOTICE OF BOARD MEETING
Regulatory Filings
2024-03-13 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 29 FEBRUARY 2024
Regulatory Filings
2024-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Regulatory Filings
2024-03-01 English
Overseas Regulatory Announcement
Earnings Release FY 2023
2024-02-27 English
Announcement Pursuant to Rule 13.18 of the Listing Rules
Capital/Financing Update
2024-02-16 English
CHANGE OF DIRECTOR
Board/Management Information
2024-02-09 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2024-02-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2024
Regulatory Filings
2024-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
Regulatory Filings
2024-02-01 English
Overseas Regulatory Announcement
Earnings Release FY 2023
2024-01-18 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information
2024-01-16 English
PROFIT WARNING
Earnings Release FY 2023
2024-01-05 English
(1) RESIGNATION OF EXECUTIVE DIRECTOR, AUTHORISED REPRESENTATIVE AND SERVICE AGENT&#x3b; (2) APPOINTMENT OF AUTHORISED REPRESENTATIVE AND SERVICE AGENT&#x3b; AND (3) CHANGE IN COMPOSITION OF NOMINATIO
Board/Management Information
2024-01-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
Regulatory Filings
2024-01-03 English
Supplemental Announcement in relation to Connected Transaction Formation of Limited Partnership Fund
Capital/Financing Update
2024-01-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2023
Regulatory Filings
2024-01-02 English